Received Apr 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLUX | INFLUENZA (SEASONAL) (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | OT |
| HPVX | HPV (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | X007193 | OT |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | X009193 | OT |
No adverse event; Product origin unknown; Improper storage of product in use; This spontaneous report was received from vaccine provider and refers to a 12-year-old male patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 28-Oct-2024, the patient was vaccinated with improperly storage doses of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL9) or Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (GARDASIL) (reported as HPV) (Product origin unknown), invalid lot #X009193, expiration date: 06-Jun-2026, administered by Intramuscular route; Meningococcal vaccine B (MenB) lot#A2743, expiration date: 30-Sep-2027), administered by Intramuscular route, and Influenza vaccine (Fluzone) lot# UT8485LA, expiration date: 30-Jun-2026, administered by Intramuscular route (lot # was not reported). All the vaccines were administered for prophylaxis. No additional adverse events were reported.